Trends in Medicare Supplemental Insurance and Prescription Drug Benefits, 1996-2001 Data UpdateThis data update provides estimates of supplemental insurance and prescription drug coverage rates and trends between 1996 and 2001, which will help to provide important context for assessing future changes in supplemental insurance and drug coverage rates after provisions…
Amid heightened public concern, the cost of prescription drugs is the focus of renewed attention by the Trump administration, the Biden campaign and lawmakers in Congress and state capitals. Proposed actions range from sweeping health care system changes to targeted initiatives that could affect Medicare, Medicaid and private insurance. See KFF’s research, analysis and public opinion data, as well as Kaiser Health News’ journalism, related to prescription drugs and their costs.
Featured Prescription Drugs Resources
KFF Health Tracking Poll – October 2019: Health Care In The Democratic Debates, Congress, And The Courts
This poll examines health care issues in the Democratic presidential primary , government negotiation of prescription drug prices, party trust on health care, Medicare-for-all, and the pending Texas v. US lawsuit affecting the Affordable Care Act and pre-existing condition protections.
Poll Finding See More
Related Prescription Drugs Resources
- Assessing Drug Price Increases in Medicare Part D and the Implications of Inflation Limits
- 10 FAQs on Prescription Drug Importation
- Pricing and Payment for Medicaid Prescription Drugs
- Management and Delivery of the Medicaid Pharmacy Benefit
- Understanding the Medicaid Prescription Drug Rebate Program
- A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries
- Kaiser Health News Coverage of Prescription Drug Issues
- What are the recent and forecasted trends in prescription drug spending?
- What’s the Latest on Medicare Drug Price Negotiations?
- How Will The Medicare Part D Benefit Change Under Current Law and Leading Proposals?
- Medicaid’s Prescription Drug Benefit: Key Facts
- Prescription Drug Rebates, Explained
- Who is Most Likely to Have High Prescription Drug Costs?
- Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control
- 10 Essential Facts About Medicare and Prescription Drug Spending
- Utilization and Spending Trends in Medicaid Outpatient Prescription Drugs, 2014-2017
- How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?
What’s the Latest on Prescription Drug Proposals from the Trump Administration, Congress, and the Biden Campaign?
This slideshow explains the similarities and differences among major proposals to lower prescription drug costs introduced by the Trump Administration, members of Congress, and the Biden campaign.
Slideshow See More
- view as grid
- view as list
This report, Reactions to the New Medicare Drug Law, produced jointly by a bipartisan team of pollsters from Public Opinion Strategies and Peter D. Hart Research Associates, presents key findings from ten focus groups of people on Medicare in three cities: Pittsburgh, PA; Kansas City, KS, and Washington, DC. The…
This chartpack includes recent survey results on the Medicare prescription drug law and seniors' use of the Internet.Chartpack (.pdf)
Tricia Neuman, Vice President and Director of the Medicare Policy Project for the Kaiser Family Foundation, testified on Monday, May 17, at a U.S. Senate Committee on Aging hearing on issues relating to retiree health coverage, “Access to Adequate Health Insurance: How Does the Equal Employment Opportunity Commission’s Recent Rule…
The Medicare Prescription Drug Discount Card Program: Implications for Low-income Medicare Beneficiaries
– Issue PaperThis Issue Paper describes the discount card and low-income assistance programs and discusses their implications for low-income Medicare beneficiaries and state Medicaid programs.Issue Paper (.pdf)
This article, published online by Health Affairs on April 14, 2004, estimates the extent to which prescription drug discount cards could affect out-of-pocket spending by Medicare beneficiaries who lack drug coverage, based on an analysis of the Medicare Current Beneficiary Survey. The Medicare discount card program is scheduled to go…
March/April 2004 Kaiser Health Poll Report Survey – Selected Findings on the Knowledge and Understanding of the New Medicare Rx Drug Program (Toplines)
Toplines of selected findings of the March/April 2004 Kaiser Family Foundation Health Poll Report survey that underscores the need to educate seniors about the new Medicare prescription drug program.Survey Toplines (.pdf)
Selected Findings on Knowledge and Understanding of the New Medicare Rx Drug Program — March/April 2004 Kaiser Health Poll Report Survey
Selected findings from the March/April 2004 Kaiser Family Foundation Health Poll Report survey underscores the need to educate seniors about the new Medicare prescription drug program – both the transitional discount card program that will be go into effect on June 1, 2004 and the full Medicare benefit that begins…
March/April 2004 Kaiser Health Poll Report Survey – Selected Findings on the Knowledge and Understanding of the New Medicare Rx Drug Program (Chartpack)
A chartpack of selected findings of the March/April 2004 Kaiser Family Foundation Health Poll Report survey that underscores the need to educate seniors about the new Medicare prescription drug program.Survey Chartpack (.pdf)
Selected Survey Findings on the New Medicare Rx Drug Law – ChartpackSeniors are confused about the Medicare prescription drug law. Below is a series of chart illustrating selected findings from the January/February 2004 Kaiser Health Poll Report survey. The findings show that while about two-thirds of seniors report following the…